- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01697943
Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Quality of Life in Patients Undergoing Total Gastrectomy (GCQOL02)
A Pilot Randomized Controlled Trial Examining the Differences of Quality of Life of Roux-En-Y Pouch Reconstruction and Conventional Roux-En-Y Reconstruction in Patients Undergoing Total Gastrectomy.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Total gastrectomy has been indicated mainly for advanced gastric cancer located from the upper to middle third of the stomach or multiple gastric cancers.The most common method of creating a way for food is called a "Roux-en-Y", in which one part of the intestines is connected with the end of the esophagus (the swallowing tube) in the abdomen, and another connection is made between the intestines ' lower down.
Patients with total gastrectomy suffer from poor food intake, anemia, and poor digestion because of loss of gastric reservoir or a lack of normal hormonal secretion for digestion. It often is associated with a limitation of postoperative quality of life (QOL). To improve postoperative nutritional status and QOL, surgeons have tried to establish ideal reconstruction after total gastrectomy and the optimum procedure for reconstruction has been discussed.
This study will compare the postoperative quality of life (QOL) of gastric pouch reconstruction with the usual reconstruction to see if the pouch makes patients feel better.
Study Type
Enrollment (Anticipated)
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200032
- Recruiting
- Fudan University Shanghai Cancer Center
-
Contact:
- Ya Nong Wang, MD,PhD
- Phone Number: 1208 +86-21 64175590
- Email: huahuang@fudan.edu.cn
-
Contact:
- Hua Huang, MD,PhD
- Phone Number: 1205 +86-21 64175590
- Email: huahuang@fudan.edu.cn
-
Principal Investigator:
- Ya Nong Wang, MD,PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Pathologically confirmed gastric malignant tumor at fUSCC (biopsy may be performed at other institutions but slides must be confirmed at SHCA, as is routine care at our institution) , and the patients be assessed must be carried out total gastrectomy by three specialists.
- Patients 20-75 years old
- Normal organ function, able to tolerate surgery, no clear contraindication for surgery
- No evidence of metastases of adjacent organs
- be able to provide follow-up over 2 years
- No specific treatment for gastric cancer before surgery
- In line with the Declaration of Helsinki and the requirements of the hospital ethics committee.
- The subjects were able to understand and comply with the trial protocol, and signed informed consent.
Exclusion Criteria:
• Synchronous or metachronous (less than five years) and with other malignancies.
- Cirrhosis and portal hypertension
- Associated with blood diseases
- Serious heart/ lung and kidney dysfunction or with metabolic diseases such as diabetes, hyperthyroidism.
- Suffering from a serious neurological diseases or psychological diseases affecting the life
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Roux-En-Y Pouch Reconstruction or Roux-En-Y Reconstruction
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in QOL (Quality of Life)
Time Frame: 5years
|
From preoperative following total gastrectomy, as measured with the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-STO22 questionnaires
|
5years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Nutritional status of patients
Time Frame: 5 years
|
5 years
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-44-563
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Tumor
-
Korea University Anam HospitalCompletedGastric Subepithelial TumorKorea, Republic of
-
National Cancer Center, KoreaUnknownGastric Subepithelial TumorKorea, Republic of
-
Medical University of ViennaUnknownSmall Gastric Subepithelial Tumor
-
Changhua Christian HospitalCompletedGastric Subepithelial Tumor
-
Panolos BioscienceRecruitingMetastatic Colorectal Cancer | Hepatocellular Carcinoma | Gastric Cancer | Solid Tumor | Advanced Solid Tumor | Solid Tumor, AdultKorea, Republic of
-
Seoul National University HospitalUnknownEarly Gastric Cancer | Gastric TumorKorea, Republic of
-
Kyunghee University Medical CenterCompleted
-
Medicina e Arte OnlusIstituti Ospitalieri di Cremona; Azienda Sanitaria Locale di Cremona; Azienda... and other collaboratorsUnknown
-
Memorial Sloan Kettering Cancer CenterTerminatedGastric Cancer | Esophageal Cancer | Esophageal Neoplasms | Gastroesophageal Junction Cancer | Gastric Tumor | Gastroesophageal Junction Adenocarcinoma | GastroEsophageal Cancer | Esophageal Tumor | Esophagogastric Tumors | Gastroesophageal Junction TumorUnited States
-
City of Hope Medical CenterCompletedGastric Cancer | Gastric Adenocarcinoma | Gastric Cancer Stage IV | Gastric Neoplasm | Gastric Cancer Metastatic to Lung | Gastric Cancer Stage | Gastric Cancer Metastatic to Liver | Gastric Cancer Stage III | Gastric Cancer Stage II | Gastric Lesion | Gastric Cancer in Situ | Gastric Cancer Stage IIIB | Gastric... and other conditionsUnited States, Japan
Clinical Trials on Roux-En-Y Pouch Reconstruction or Conventional Roux-En-Y Reconstruction
-
Jilin UniversityUnknown
-
Gangnam Severance HospitalCompletedGastric Cancer | Diabetes Mellitus Type 2 in NonobeseKorea, Republic of
-
Wakayama Medical UniversityUnknownPancreatic Neoplasms | Pancreatitis | Bile Duct Neoplasms | Duodenal Neoplasms | Ampullary NeoplasmsJapan
-
National Healthcare Group, SingaporeChinese University of Hong Kong; Tan Tock Seng Hospital; Changi General HospitalCompletedStomach Cancer | Gastric Cancer | GastrectomySingapore, Hong Kong
-
Korea University Anam HospitalGuangdong Provincial Hospital of Traditional Chinese Medicine; Shanghai Jiao... and other collaboratorsRecruitingDiabetes Mellitus, Type 2 | Gastric CancerKorea, Republic of
-
Kyungpook National University Chilgok HospitalCompletedDiabetes Mellitus, Type 2 | Stomach NeoplasmKorea, Republic of
-
Wakayama Medical UniversityCompleted
-
The First Affiliated Hospital with Nanjing Medical...Unknown
-
West China HospitalUnknownQuality of Life | Gastric Cancer | Complication | Roux-en-y Anastomosis Site | Gastric Anastomosis (Site)China
-
Jilin UniversityUnknown